We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$21B
AUM Growth
+$1.82B
Cap. Flow
+$406M
Cap. Flow %
1.93%
Top 10 Hldgs %
18.08%
Holding
144
New
8
Increased
70
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
STE icon
Steris
STE
+$339M
2
PLAN
Anaplan, Inc.
PLAN
+$138M
3
CSGP icon
CoStar Group
CSGP
+$86M
4
MRVI icon
Maravai LifeSciences
MRVI
+$67.7M
5
LESL icon
Leslie's
LESL
+$67.2M

Sector Composition

Rank Sector Weight
1 Healthcare 24.84%
2 Technology 20.7%
3 Industrials 14.5%
4 Consumer Staples 12.97%
5 Financials 12.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBTM
26
JBT Marel
JBTM
$7.35B
$246M 1.17%
1,723,595
-2,385
-0.1% -$333K
ZS icon
27
Zscaler
ZS
$24.9B
$240M 1.14%
1,113,065
-150
-0% -$28.5K
CLVT icon
28
Clarivate
CLVT
$1.37B
$238M 1.13%
8,656,480
+24,400
+0.3% +$671K
TTC icon
29
Toro Company
TTC
$8.79B
$237M 1.13%
2,160,791
+355,890
+20% +$39.1M
TSCO icon
30
Tractor Supply
TSCO
$16.3B
$223M 1.06%
6,004,075
-1,434,225
-19% -$52.6M
PB icon
31
Prosperity Bancshares
PB
$8.9B
$222M 1.06%
3,095,225
+22,840
+0.7% +$1.71M
OKTA icon
32
Okta
OKTA
$23.8B
$214M 1.02%
873,874
+217,505
+33% +$52.5M
NDSN icon
33
Nordson
NDSN
$16.4B
$211M 1%
962,687
-4,818
-0.5% -$1.02M
VEEV icon
34
Veeva Systems
VEEV
$33.8B
$206M 0.98%
663,502
-58,195
-8% -$16.2M
SMAR
35
DELISTED
Smartsheet Inc.
SMAR
$205M 0.98%
2,839,465
+15,555
+0.6% +$971K
CNMD icon
36
CONMED
CNMD
$1.3B
$203M 0.96%
1,475,989
-228,950
-13% -$31.3M
TECH icon
37
Bio-Techne
TECH
$11.2B
$200M 0.95%
1,780,960
-555,120
-24% -$58.4M
AQUA
38
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$198M 0.94%
5,847,725
-47,685
-0.8% -$1.43M
SMPL icon
39
Simply Good Foods
SMPL
$907M
$194M 0.92%
5,305,059
-719,306
-12% -$24.6M
NTRS icon
40
Northern Trust
NTRS
$21.8B
$193M 0.92%
1,670,655
-255,565
-13% -$29.3M
MSA icon
41
Mine Safety
MSA
$6.79B
$189M 0.9%
1,141,025
+144,925
+15% +$23.5M
SIVB
42
DELISTED
SVB Financial Group
SIVB
$188M 0.89%
337,329
-3,315
-1% -$1.84M
COO icon
43
Cooper Companies
COO
$14.2B
$186M 0.89%
1,880,040
-254,080
-12% -$24.9M
LW icon
44
Lamb Weston
LW
$7.42B
$184M 0.87%
2,277,112
-317,270
-12% -$25.4M
SNPS icon
45
Synopsys
SNPS
$71.6B
$180M 0.86%
652,295
-2,680
-0.4% -$680K
ROK icon
46
Rockwell Automation
ROK
$51.1B
$177M 0.84%
619,052
-1,425
-0.2% -$384K
TAP icon
47
Molson Coors Class B
TAP
$8.02B
$176M 0.84%
3,285,550
-15,870
-0.5% -$887K
TWNK
48
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$175M 0.83%
10,838,790
-28,840
-0.3% -$450K
IEX icon
49
IDEX
IEX
$17B
$170M 0.81%
774,300
-480
-0.1% -$106K
BIO icon
50
Bio-Rad Laboratories Class A
BIO
$8.76B
$168M 0.8%
261,315
+1,915
+0.7% +$1.17M

Similar funds

Champlain Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Champlain Investment Partners held 144 positions worth $21B, up 9.5% from $19.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners's Q2 2021 filing shows 8 new, 70 increased, 59 reduced and 5 closed positions. Its largest new stake was Steris: 1,685,437 shares worth $348M. The largest sale was Cantel Medical Corporation, an estimated $320M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q2 2021 buy was Steris: 1,685,437 shares worth $348M.
  • Champlain Investment Partners added most to Maravai LifeSciences in Q2 2021, an estimated $67.7M increase.
  • Champlain Investment Partners's biggest Q2 2021 reduction was Ulta Beauty, cutting an estimated $63.1M.
  • Champlain Investment Partners fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $320M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $21B portfolio in Q2 2021.
  • Champlain Investment Partners opened 8 new positions and closed 5 in Q2 2021.
  • Champlain Investment Partners's portfolio value rose 9.5% quarter-over-quarter to $21B.

Based on Champlain Investment Partners's 13F filing for Q2 2021, filed 12 Aug 2021.